Back
Xvivo Perfusion AB Vs. Pro-Dex Industry Stock Comparison
Buy
72
XVIPF
Xvivo Perfusion AB
Last Price:
$44.60
Seasonality Move:
-0.25%
Buy
68
PDEX
Pro-Dex
Last Price:
$51.49
Seasonality Move:
10.27%
Buy
72
Xvivo Perfusion AB (XVIPF)
is a Buy
Is Xvivo Perfusion AB a Buy, Sell or Hold?
-
The current Xvivo Perfusion AB [XVIPF] share price is $44.60. The Score for XVIPF is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
XVIPF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XVIPF Stock Price Chart
What is Xvivo Perfusion AB's stock price today?
-
The Xvivo Perfusion AB share price today is $44.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XVIPF is experiencing slight buying pressure.
XVIPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 67.24 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.97 - 43.47) | Buy |
Bollinger Bands (100): | (41.89 - 49.01) | Sell |
PDEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 55.69 | Buy |
Chaikin Money Flow: | -20256 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.32 - 52.22) | Buy |
Bollinger Bands (100): | (24.46 - 47.06) | Buy |
XVIPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.14 | Buy |
20-day SMA: | 42.06 | Buy |
50-day SMA: | 42.23 | Buy |
200-day SMA: | 41.9 | Buy |
8-day EMA: | 42.76 | Buy |
20-day EMA: | 42.25 | Buy |
50-day EMA: | 42.9 | Buy |
200-day EMA: | 41.01 | Buy |
PDEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.35 | Buy |
20-day SMA: | 48.53 | Buy |
50-day SMA: | 45.81 | Buy |
200-day SMA: | 27.28 | Buy |
8-day EMA: | 50.13 | Buy |
20-day EMA: | 48.86 | Buy |
50-day EMA: | 44.85 | Buy |
200-day EMA: | 31.31 | Buy |
Xvivo Perfusion AB Earnings Growth & XVIPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and an increase next year of $0.06 per share.
Xvivo Perfusion AB Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pro-Dex Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |